Specifically, we have reported that supplementation with both EGCG and BCAA suppresses obesity-related colorectal carcinogenesis in db/db mice by reducing serum levels of insulin and inhibiting activation of the IGF/IGF-1R signaling pathway in the colonic mucosa [45,84]. The gene discussed is IGF1R; the disease is Obesity.